Hypothesis Development Award – HT942524GBMRPHDA
- up to USD$200,00 for Single PI Option or up to USD$300,000 for Partnering PI Option, over 2 years
- Letters of Intent due 6 November 2024
- supports the exploration of highly innovative, untested, exploratory, potentially high-gain concepts, theories, paradigms and/or methods that address an important problem relevant to one or both of the Drug Delivery and Biomarkers focus areas
- preliminary data is strongly discouraged
- clinical research is allowed
- animal studies are allowed
- clinical trials are not allowed
- Document – Funding Opportunity: HT942524GBMRPHDA
Resource Development Award – HT942524GBMRPRDA
- up to USD$500,000 over 3 years
- Letters of Intent due 6 November 2024
- supports product-driven research focused on the advancement of pre-clinical model systems (in vitro and in vivo) that need further development, characterisation, validation or standardisation
- preliminary data required
- clinical research is allowed
- animal studies are allowed
- clinical trials are not allowed
- Document – Funding Opportunity: HT942524GBMRPRDA
